Literature DB >> 11181688

Adjuvant therapy of melanoma: at what cost?

L E Spitler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11181688     DOI： 10.1200/JCO.2001.19.4.1226

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer.

Authors:  M Lotem; T Peretz; O Drize; Z Gimmon; D Ad El; R Weitzen; H Goldberg; I Ben David; D Prus; T Hamburger; E Shiloni
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.